TY - JOUR
T1 - Improving the managed introduction of new medicines
T2 - sharing experiences to aid authorities across Europe
AU - Matusewicz, Wojciech
AU - Godman, Brian
AU - Bak Pedersen, Hanne
AU - Fürst, Jurij
AU - Gulbinovič , Jolanta
AU - Mack, Asbjørn
AU - Selke, Gisbert
AU - Timoney, Angela
AU - Warmińska, Ewa
AU - Malmström, Rickard E
PY - 2015/9/14
Y1 - 2015/9/14
N2 - The 3-day course on the managed introduction of new drugs was organised by the Piperska group together with the Agency for Health Technology Assessment and Tariff System (AOTMiT) and WHO Europe to share experiences and case histories among health authority and health insurance company personnel, academics and those from commercial organisations from across Europe on potential ways to optimise the managed entry of new medicines. This starts pre-launch with horizon scanning and budgeting, then peri-launch including critical drug evaluation, and finally post launch including monitoring prescribing of new medicines against agreed guidance and indicators. There were also discussions on issues regarding managed entry schemes and procurement strategies including biosimilars.
AB - The 3-day course on the managed introduction of new drugs was organised by the Piperska group together with the Agency for Health Technology Assessment and Tariff System (AOTMiT) and WHO Europe to share experiences and case histories among health authority and health insurance company personnel, academics and those from commercial organisations from across Europe on potential ways to optimise the managed entry of new medicines. This starts pre-launch with horizon scanning and budgeting, then peri-launch including critical drug evaluation, and finally post launch including monitoring prescribing of new medicines against agreed guidance and indicators. There were also discussions on issues regarding managed entry schemes and procurement strategies including biosimilars.
KW - biosimilars
KW - horizon scanning
KW - managed entry schemes
KW - medicines
UR - http://informahealthcare.com/loi/erp
UR - http://www.tandfonline.com/doi/full/10.1586/14737167.2015.1085803
U2 - 10.1586/14737167.2015.1085803
DO - 10.1586/14737167.2015.1085803
M3 - Article
SN - 1473-7167
VL - 15
SP - 755
EP - 758
JO - Expert Review of Pharmacoeconomics and Outcomes Research
JF - Expert Review of Pharmacoeconomics and Outcomes Research
IS - 5
ER -